Sep . 29, 2025 05:35 Back to list

HPV 28 Genotyping Kit - Taizhou Cowingene Biotech | PCR Detection, Accurate HPV Testing

The Cowingene HPV 28 Genotyping Detection Kit represents a significant advancement in molecular diagnostics, offering a reliable and efficient solution for detecting 28 high-risk human papillomavirus (HPV) strains. This article explores the product's core features, technical specifications, application scenarios, and the company's commitment to innovation.

Product Overview

The Cowingene HPV 28 Genotyping Detection Kit is a PCR-based diagnostic tool designed for the identification of 28 HPV genotypes, including 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73, 81, 82, and 83. This comprehensive coverage aligns with global guidelines for cervical cancer screening, ensuring early detection and risk assessment.

HPV 28 Genotyping Kit - Taizhou Cowingene Biotech | PCR Detection, Accurate HPV Testing

Key Features

High Sensitivity and Specificity: The kit utilizes advanced PCR technology to detect even low viral loads, minimizing false negatives and ensuring accurate results.
Broad Genotype Coverage: It targets 28 HPV genotypes, including the most prevalent high-risk strains associated with cervical cancer.
Versatile Sample Compatibility: Validated for cervical swabs, urine, and self-collected vaginal specimens, making it suitable for diverse clinical settings.
User-Friendly Workflow: Streamlined protocols reduce hands-on time, enhancing efficiency in high-throughput laboratories.

Technical Specifications

Product Name	Cowingene HPV 28 Genotyping Detection Kit
Company	Taizhou Cowingene Biotech Co., Ltd.
Validated Specimens	Cervical swab, Urine, Self-collected vaginal
HPV Analytes	8 tubes; 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83
Technology	PCR-based amplification with real-time detection
Application	Cervical cancer screening, HPV genotyping, and risk stratification

Advantages of the Cowingene HPV 28 Genotyping Kit

The Cowingene HPV 28 Genotyping Detection Kit offers several advantages over traditional methods:

Enhanced Diagnostic Accuracy: The kit's design ensures precise differentiation between HPV genotypes, critical for determining cancer risk.
Cost-Effective Testing: By reducing the need for multiple assays, it lowers overall testing costs while maintaining high performance.
Scalable for High-Throughput Laboratories: The kit is optimized for automation, making it ideal for large-scale screening programs.
Compliance with Global Standards: Developed in accordance with international guidelines for HPV detection and cervical cancer prevention.

Application Scenarios

The Cowingene HPV 28 Genotyping Detection Kit is well-suited for various clinical and research settings:

Gynecological Clinics: Facilitates early detection of high-risk HPV infections, enabling timely intervention.
Public Health Programs: Supports large-scale cervical cancer screening initiatives, particularly in resource-limited regions.
Research Institutions: Provides a reliable tool for studying HPV prevalence and its correlation with cervical cancer.

Company Background

Taizhou Cowingene Biotech Co., Ltd. is a leading innovator in molecular diagnostics, dedicated to developing cutting-edge solutions for infectious disease detection. With a focus on PCR-based technologies, the company has established itself as a trusted partner for healthcare providers worldwide. Their commitment to quality and accuracy is reflected in the Cowingene HPV 28 Genotyping Detection Kit, which combines advanced science with user-centric design.

Authoritative Citations

The importance of accurate HPV detection is underscored by the National Institute of Standards and Technology (NIST), which emphasizes the role of standardized testing in public health. According to NIST, "Precise measurements and reliable diagnostic tools are essential for ensuring the efficacy of medical technologies" (NIST, 2025).

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit exemplifies the intersection of innovation and clinical need. By offering a comprehensive, accurate, and user-friendly solution for HPV detection, it empowers healthcare professionals to improve patient outcomes. For more information, visit Taizhou Cowingene Biotech Co., Ltd..